ArticleRheumatology (Oxford, England)2025

Targeting interferon responses in juvenile dermatomyositis: Siglec-1 as an in vitro biomarker for JAK inhibitor efficacy.

Saskia R Veldkamp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.